BioCardia Announces Two Presentations Related To CardiAMP Cell Therapy At Cardiovascular Research Technologies In Washington, DC

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia®, Inc., a leader in cardiovascular regenerative medicine, announced today two presentations related to CardiAMP cell therapy at the Cardiovascular Research Technologies (CRT 2016) meeting in Washington DC.

MORE ON THIS TOPIC